CVS Health (CVS) Stock Looks Reasonable On Fresh Vaccine Access News - Simply Wall Street

CX Institutional lessened its position in shares of CVS Health Corporation (NYSE:CVS - Free Report) by 86.0% in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 14,141 shares of the pharmacy operator's stock after selling 86,515 shares during the period. CX Institutional's holdings in CVS Health were worth $1,212,000 at the end of the most recent reporting period. One Comment on CVS's Earnings Call Sent the Stock TumblingOther large investors have also recently bought and sold shares of the company. BlackRock Inc. bought a new position in shares of CVS Health during the 2nd quarter worth approximately $12,747,462,000. State Street Corp increased its stake in shares of CVS Health by 26.3% in the 2nd quarter. State Street Corp now owns 74,927,064 shares of the pharmacy operator's stock valued at $7,751,205,000 after acquiring an additional 15,604,883 shares in the last quarter. Bank of America Corp DE lifted its position in shares of CVS Health by 148.0% during the 2nd quarter.

Evercore ISI analyst Elizabeth Anderson CFA maintained a Buy rating on CVS Health today and set a price target of $125.00. Anderson CFA covers the Healthcare sector, focusing on stocks such as Charles River Labs, Doximity, and Align Tech. According to TipRanks, Anderson CFA has an average return of 2.4% and a 50.00% success rate on recommended stocks. Currently, the analyst consensus on CVS Health is a Strong Buy with an average price target of $114.37. Based on CVS Health’s latest earnings release for the quarter ending June 30, the company reported a quarterly revenue of $106.1 billion and a net profit of $3 billion. In comparison, last year the company earned a revenue of $98.92 billion and had a net profit of $1.02 billion